[Clinical analysis of 14 infective endocarditis in patients with obstructive hypertrophic cardiomyopathy]

P Wang1, L Song2, X J Gao2

  • 1Cardiac Arrhythmia Center, Fuwai Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Beijing 100037, China.

Zhonghua Nei Ke Za Zhi
|December 1, 2020
PubMed

Insights

Infective endocarditis (IE) in hypertrophic cardiomyopathy (HCM) patients is rare but serious. Early cardiac surgery is recommended for better outcomes in these complex cases.

Area of Science:

  • Cardiology
  • Infectious Diseases

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart condition.
  • Infective endocarditis (IE) is a serious infection of the heart lining.
  • The co-occurrence of IE and HCM presents unique clinical challenges.

Purpose of the Study:

  • To analyze the clinical characteristics of patients with both infective endocarditis and hypertrophic cardiomyopathy.
  • To understand the specific manifestations, pathogens, and outcomes in this patient cohort.

Main Methods:

  • Retrospective analysis of 14 patients diagnosed with both HCM and IE.
  • Data collected included clinical manifestations, blood cultures, echocardiography, treatment, and outcomes.
  • Comparison with general IE and HCM populations where applicable.

Main Results:

  • IE in HCM patients occurred in 0.19% of HCM cases.
  • Common symptoms included fever and heart murmur; heart failure and embolism were frequent complications.
  • Echocardiography revealed vegetation in all patients, often on the mitral valve, with severe left ventricular outflow obstruction.
  • Gram-positive cocci, primarily Streptococcus, were the main pathogens.

Conclusions:

  • IE is a rare but significant complication in HCM patients.
  • Septic embolization and valve lesions are prevalent, suggesting a poorer prognosis.
  • Early cardiac surgery intervention is crucial for improving survival rates in these patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
182
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
141
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
200
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
258
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
204
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
257